相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase III Randomized trial of intravenous cisplatin plus a 24-or 96-hour infusion of paclitaxel in epithelial ovarian cancer: gynecologic oncology group study
David R. Spriggs et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Management of ovarian stromal cell tumors
Nicoletta Colombo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase II trial of the mTOR inhibitor AP23573 as a single agent in advanced endometrial cancer
N. Colombo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant
Lawrence H. Einhorn et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: A Gynecologic Oncology Group study
Howard D. Homesley et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of weekly docetaxel in patients with recurrent or metastatic endometrial cancer: AGO Uterus-4
A. R. Guenthert et al.
GYNECOLOGIC ONCOLOGY (2007)
Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study
M. A. Sovak et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers:: A Gynecologic Oncology Group study
Maurie Markman et al.
GYNECOLOGIC ONCOLOGY (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study
N Katsumata et al.
BRITISH JOURNAL OF CANCER (2005)
Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma
CM Michener et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors
J Brown et al.
GYNECOLOGIC ONCOLOGY (2005)
The effect of single weekly paclitaxel in heavily pretreated patients with recurrent or persistent advanced ovarian cancer
T Kita et al.
GYNECOLOGIC ONCOLOGY (2004)
Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus
M Toyoshima et al.
GYNECOLOGIC ONCOLOGY (2004)
The activity of taxanes in the treatment of sex cord-stromal ovarian tumors
J Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study
DH Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
PA Vasey et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
P Sabbatini et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group study
GF Fleming et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
A du Bois et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Effective weekly docetaxel for recurrent ovarian cancer: A case report
S Komiyama et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: An intergroup study
GA Omura et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group trial
M Markman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A case of chronic paclitaxel administration in ovarian cancer
VE von Gruenigen et al.
GYNECOLOGIC ONCOLOGY (2003)
Granulosa cell tumor of the ovary
ST Schumer et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study
S Lincoln et al.
GYNECOLOGIC ONCOLOGY (2003)
A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study
PG Rose et al.
GYNECOLOGIC ONCOLOGY (2003)
Long-term follow-up confirm's a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
MJ Piccart et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Paclitaxel and platinum chemotherapy for malignant mixed mullerian tumors of the ovary
LR Duska et al.
GYNECOLOGIC ONCOLOGY (2002)
Phase II trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer
M Markman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the eastern cooperative oncology group
S Hinton et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer
A Covens et al.
GYNECOLOGIC ONCOLOGY (2002)
Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: Application toward a dynamic disease state model of ovarian cancer
DS Dizon et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Paclitaxel in the treatment of carcinosarcoma of the uterus: A gynecologic oncology group study
JP Curtin et al.
GYNECOLOGIC ONCOLOGY (2001)
Results of reinduction therapy with paclitaxel and carboplatin in recurrent epithelial ovarian cancer
B Gronlund et al.
GYNECOLOGIC ONCOLOGY (2001)
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis
JA Green et al.
LANCET (2001)
Chronic administration of single-agent paclitaxel in gynecologic malignancies
J Rohl et al.
GYNECOLOGIC ONCOLOGY (2001)
Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer
PA Vasey et al.
BRITISH JOURNAL OF CANCER (2001)
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results
MJ Piccart et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
